188 related articles for article (PubMed ID: 34228458)
1.
García-Varela L; Rodríguez-Pérez M; Custodia A; Moraga-Amaro R; Colabufo NA; Aguiar P; Sobrino T; Dierckx RAJO; van Waarde A; Elsinga PH; Luurtsema G
Mol Pharm; 2021 Aug; 18(8):3073-3085. PubMed ID: 34228458
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Modeling of [
García-Varela L; Arif WM; Vállez García D; Kakiuchi T; Ohba H; Harada N; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
Mol Pharm; 2020 Sep; 17(9):3477-3486. PubMed ID: 32787277
[TBL] [Abstract][Full Text] [Related]
3. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [
Garcia-Varela L; Mossel P; Aguiar P; Vazquez-Matias DA; van Waarde A; Willemsen ATM; Bartels AL; Colabufo NA; Dierckx RAJO; Elsinga PH; Luurtsema G
J Control Release; 2022 Jul; 347():500-507. PubMed ID: 35588934
[TBL] [Abstract][Full Text] [Related]
4. Quantification of P-glycoprotein function at the human blood-brain barrier using [
Mossel P; Arif WM; De Souza GS; Varela LG; van der Weijden CWJ; Boersma HH; Willemsen ATM; Boellaard R; Elsinga PH; Borra RJH; Dierckx RAJO; Lammertsma AA; Bartels AL; Luurtsema G
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3917-3927. PubMed ID: 37552369
[TBL] [Abstract][Full Text] [Related]
5. Test-Retest Repeatability of [
García-Varela L; Vállez García D; Rodríguez-Pérez M; van Waarde A; Sijbesma JWA; Schildt A; Kwizera C; Aguiar P; Sobrino T; Dierckx RAJO; Elsinga PH; Luurtsema G
ACS Chem Neurosci; 2020 Feb; 11(4):648-658. PubMed ID: 31961646
[TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison of (R)-[
García-Varela L; Vállez García D; Aguiar P; Kakiuchi T; Ohba H; Harada N; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4307-4317. PubMed ID: 34117508
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of [
Savolainen H; Windhorst AD; Elsinga PH; Cantore M; Colabufo NA; Willemsen AT; Luurtsema G
J Cereb Blood Flow Metab; 2017 Apr; 37(4):1286-1298. PubMed ID: 27354093
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic Modeling of (
García-Varela L; García DV; Kakiuchi T; Ohba H; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
Mol Pharm; 2021 Jan; 18(1):416-428. PubMed ID: 33315404
[TBL] [Abstract][Full Text] [Related]
9. First clinical assessment of [
Toyohara J; Sakata M; Ishibashi K; Mossel P; Imai M; Wagatsuma K; Tago T; Imabayashi E; Colabufo NA; Luurtsema G; Ishii K
Ann Nucl Med; 2021 Nov; 35(11):1240-1252. PubMed ID: 34368924
[TBL] [Abstract][Full Text] [Related]
10. Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.
Pottier G; Marie S; Goutal S; Auvity S; Peyronneau MA; Stute S; Boisgard R; Dollé F; Buvat I; Caillé F; Tournier N
J Nucl Med; 2016 Feb; 57(2):309-14. PubMed ID: 26585058
[TBL] [Abstract][Full Text] [Related]
11. MC225, a Novel Probe for P-glycoprotein PET Imaging at the Blood-brain Barrier: In Vitro Cardiovascular Safety Evaluation.
Fusi F; Durante M; Gorelli B; Perrone MG; Colabufo NA; Saponara S
J Cardiovasc Pharmacol; 2017 Dec; 70(6):405-410. PubMed ID: 28877068
[TBL] [Abstract][Full Text] [Related]
12. Parametric Imaging of P-Glycoprotein Function at the Blood-Brain Barrier Using k
Breuil L; El Biali M; Vodovar D; Marie S; Auvity S; Bauer M; Goutal S; Rodrigo S; Langer O; Tournier N
Mol Imaging Biol; 2023 Dec; 25(6):1135-1141. PubMed ID: 37801196
[TBL] [Abstract][Full Text] [Related]
13. Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET.
Bankstahl JP; Kuntner C; Abrahim A; Karch R; Stanek J; Wanek T; Wadsak W; Kletter K; Müller M; Löscher W; Langer O
J Nucl Med; 2008 Aug; 49(8):1328-35. PubMed ID: 18632828
[TBL] [Abstract][Full Text] [Related]
14. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
[TBL] [Abstract][Full Text] [Related]
15. P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of
Auvity S; Caillé F; Marie S; Wimberley C; Bauer M; Langer O; Buvat I; Goutal S; Tournier N
J Nucl Med; 2018 Oct; 59(10):1609-1615. PubMed ID: 29748235
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
Traxl A; Mairinger S; Filip T; Sauberer M; Stanek J; Poschner S; Jäger W; Zoufal V; Novarino G; Tournier N; Bauer M; Wanek T; Langer O
Mol Pharm; 2019 Mar; 16(3):1282-1293. PubMed ID: 30694684
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats.
Müllauer J; Karch R; Bankstahl JP; Bankstahl M; Stanek J; Wanek T; Mairinger S; Müller M; Löscher W; Langer O; Kuntner C
Nucl Med Biol; 2013 Aug; 40(6):755-63. PubMed ID: 23774004
[TBL] [Abstract][Full Text] [Related]
18. (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.
Syvänen S; Luurtsema G; Molthoff CF; Windhorst AD; Huisman MC; Lammertsma AA; Voskuyl RA; de Lange EC
BMC Med Imaging; 2011 Jan; 11():1. PubMed ID: 21199574
[TBL] [Abstract][Full Text] [Related]
19. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
[TBL] [Abstract][Full Text] [Related]
20. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
